Characterization of a novel anti-CD20 Stradobody™ with potent in vitro anti-tumor activity

被引：0
|
作者：
Zhang, Xiaoyu [1 ]
Burch, Erin [1 ]
Chen, Shaodong [1 ]
Sallin, Michelle [1 ]
Olsen, Henrik [2 ]
Block, David [2 ]
Strome, Scott [1 ]
机构：
[1] Univ Maryland, Sch Med, Otorhinolaryngol Head & Neck Surg, Baltimore, MD 21201 USA
[2] Gliknik Inc, Baltimore, MD USA
来源：
JOURNAL OF IMMUNOLOGY | 2014年 / 192卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
TUM7P.935
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Characterization of a Novel Humanized Anti-CD20 Antibody with Potent Anti-Tumor Activity against Non-Hodgkin's Lymphoma
    Zhang, Haifeng
    Song, Liping
    Ye, Hongtu
    Hu, Lide
    Liang, Wenlu
    Liu, Datao
    [J]. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2013, 32 (03) : 645 - 654
  • [2] Development of novel tetravalent anti-CD20 antibodies with potent antitumor activity
    Li, Bohua
    Shi, Shu
    Qian, Weizhu
    Zhao, Lei
    Zhang, Dapeng
    Hou, Sheng
    Zheng, Lai
    Dai, Jianxin
    Zhao, Jian
    Wang, Hao
    Guo, Yajun
    [J]. CANCER RESEARCH, 2008, 68 (07) : 2400 - 2408
  • [3] Development of novel tetravalent anti-CD20 antibodies with potent antitumor activity
    Guo, Yajun
    Li, Bohua
    Shi, Shu
    Wang, Hao
    [J]. JOURNAL OF BIOTECHNOLOGY, 2008, 136 : S174 - S175
  • [4] Characterization of a novel class of RAS inhibitory compounds with potent anti-tumor activity
    Ward, Antonio
    Chen, Xi
    Valiyaveettil, Jacob
    Zhu, Bing
    Ramirez-Alcantara, Veronica
    Lee, Kevin J.
    Lindsey, Ashley
    Berry, Kristy
    Mattox, Tyler E.
    McConnell, Kate
    Boyd, Michael R.
    Piazza, Gary A.
    Keeton, Adam B.
    [J]. CANCER RESEARCH, 2017, 77
  • [5] Synergistic anti-tumor activity of acadesine (AICAR) in combination with the anti-CD20 monoclonal antibody rituximab in in vivo and in vitro models of mantle cell lymphoma
    Montraveta, Arnau
    Xargay-Torrent, Silvia
    Lopez-Guerra, Monica
    Rosich, Laia
    Perez-Galan, Patricia
    Salaverria, Itziar
    Bea, Silvia
    Kalko, Susana G.
    de Frias, Merce
    Campas, Clara
    Roue, Gael
    Colomer, Dolors
    [J]. ONCOTARGET, 2014, 5 (03) : 726 - 739
  • [6] Maytansinoid conjugates of a novel type III anti-CD20 antibody with potent antitumor activity.
    Deckert, Jutta
    Park, Peter U.
    Yi, Yong
    Chickias, Sharon
    Li, Min
    Maloney, Erin K.
    Wu, Rui
    Lanieri, Leanne
    Coccia, Jennifer A.
    Ponte, Joe
    Rui, Lingyun
    Tavares, Daniel J.
    Pinkas, Jan
    Chittenden, Thomas
    [J]. CANCER RESEARCH, 2013, 73 (08)
  • [7] Ofatumumab (OFA) Is a Novel Anti-CD20 Monoclonal Antibody (mAb) with Improved Anti-Tumor Activity in Vitro and in Vivo in Mantle Cell Lymphoma (MCL) Pre-Clinical Models
    Barth, Matthew J.
    Pendurti, Gopichand
    Tsai, Ping-Chiao
    Mavis, Cory
    Klener, Pavel, Jr.
    Czuczman, Myron S.
    Hernandez-Ilizaliturri, Francisco
    [J]. BLOOD, 2012, 120 (21)
  • [8] BLOCKING B-CELLS (ANTI-CD20/ANTI-CD20)
    Isenberg, David A.
    [J]. RHEUMATOLOGY, 2015, 54 : 1 - 1
  • [9] TETROCARCINS, NOVEL ANTI-TUMOR ANTIBIOTICS .2. ISOLATION, CHARACTERIZATION AND ANTI-TUMOR ACTIVITY
    TAMAOKI, T
    KASAI, M
    SHIRAHATA, K
    OHKUBO, S
    MORIMOTO, M
    MINEURA, K
    ISHII, S
    TOMITA, F
    [J]. JOURNAL OF ANTIBIOTICS, 1980, 33 (09): : 946 - 950
  • [10] Bispecific Anti-CD20/Anti-CD22 Antibodies with Potent Lymphoma Cytotoxicity
    Rossi, Edmund A.
    Chang, Chien-Hsing
    Cardillo, Thomas M.
    Stein, Rhona
    Pilas, Diana
    Nordstrom, Diane L.
    Kopinski, John
    Goldenberg, David M.
    [J]. BLOOD, 2008, 112 (11) : 564 - 565
12345